About
Research
Products
Investors
Careers
Agenda
fr
Press Releases
Our latest news and press releases
All
2018
2017
2016
2015
2014
23
Jun
2017
12:47 E.S.T.
Calyxt Files Registration Statement for Proposed Initial Public Offering
Read more
09
Jun
2017
16:30 E.S.T.
Annual General Meeting of June 26, 2017
Read more
10
May
2017
16:30 E.S.T.
Cellectis Patent Encompassing Broad Uses of Gene Editing Technologies Maintained by USPTO
Read more
09
May
2017
16:30 E.S.T.
Cellectis Reports 1st Quarter 2017 Financial Results
Read more
27
Apr
2017
16:30 E.S.T.
Cellectis CEO Selected as Speaker for 2017 Milken Institute Global Conference
Read more
25
Apr
2017
16:30 E.S.T.
Cellectis to Present at the American Society of Gene & Cell Therapy Annual Meeting
Read more
12
Apr
2017
16:30 E.S.T.
Cellectis S.A. to Explore Possible Initial Public Offering of Calyxt, Inc.
Read more
31
Mar
2017
16:30 E.S.T.
Cellectis to Present at the 2017 Annual Conference of the American Association for Cancer Research
Read more
09
Mar
2017
16:30 E.S.T.
Servier and Pfizer announce FDA clearance of IND application for UCART19 in Adult Relapsed/Refractory Acute Lymphoblastic Leukemia
Read more
07
Mar
2017
16:30 E.S.T.
Five Additional Leading Physicians to Join Cellectis Clinical Advisory Board
Read more
Prev
1
2
3
4
Next